Mantle cell lymphoma (MCL) is an aggressive lymphoid cancer characterised by iterative
clinical relapses and short survival. MCL displays complex genetics and hallmarks of …

Mantle cell lymphoma (MCL) is a mostly incurable malignancy arising from naive B cells
(NBCs) in the mantle zone of lymph nodes. We analyzed genomewide methylation in MCL …

The prognosis of advanced mantle cell lymphoma (MCL) is poor [1]. Analyses of genomic
and epi-genomic landscapes indicate a critical role for the DNA methylome and its interplay …

[eng] Mantle cell lymphoma (MCL) is an aggressive lymphoid neoplasm derived from mature
B cells characterized by the presence of the t (11; 14)(q13; q32) translocation that leads to …

Mantle cell lymphoma (MCL) is a B‐cell neoplasm with an aggressive clinical behavior
characterized by the t (11; 14)(q13; q32) and cyclin D1 overexpression. To clarify the …

Background Mantle cell lymphoma (MCL) is genetically characterized by the t (11; 14)(q13;
q32) translocation and a high number of secondary chromosomal alterations. The …

Objective: The function of euchromatic histone-lysine N-methyltransferase 2 (EHMT2) has
been studied in several cancers; however, little is known about its role in mantle cell …

While studies have identified a number of mutations in mantle cell lymphoma (MCL), the list
may still be incomplete and contribution to the pathogenesis remains unclear. We analyzed …

Abstract Abstract 673 Mantle Cell Lymphoma (MCL) is an aggressive and incurable
malignancy arising from naïve B cells (NBC) in the mantle zone of lymph node follicles …

Introduction Premature senescence, a terminal cell-cycle arrest condition of viable cells in
response to acute cellular stresses such as oncogenic activation or DNA-damaging …